Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Related Citations for PubMed (Select 23036031)

1.

Association between antimicrobial locks for hemodialysis central venous catheters and antibiotic resistance.

Wolley MJ, Taylor SL, Hossain F, Abbas SA, Marshall MR.

Hemodial Int. 2012 Oct;16 Suppl 1:S2-9. doi: 10.1111/j.1542-4758.2012.00740.x.

PMID:
23036031
2.

Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.

Davenport A; Pan Thames Renal Audit Peritoneal Dialysis Group.

J Nephrol. 2012 Sep-Oct;25(5):819-24. doi: 10.5301/jn.5000071.

PMID:
22241640
3.

The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis.

Pierce DA, Williamson JC, Mauck VS, Russell GB, Palavecino E, Burkart JM.

Perit Dial Int. 2012 Sep-Oct;32(5):525-30. Epub 2012 Feb 1.

4.

Hemodialysis catheter-related bacteremia in children: increasing antibiotic resistance and changing bacteriological profile.

Araya CE, Fennell RS, Neiberger RE, Dharnidharka VR.

Am J Kidney Dis. 2007 Jul;50(1):119-23.

PMID:
17591531
5.

Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin.

Silva TN, Mendes ML, AbrĂ£o JM, Caramori JT, Ponce D.

Int Urol Nephrol. 2013 Oct;45(5):1405-13. doi: 10.1007/s11255-012-0339-1. Epub 2012 Dec 27.

PMID:
23269457
6.

Anti-microbial locks increase the prevalence of Staphylococcus aureus and antibiotic-resistant Enterobacter: observational retrospective cohort study.

Dixon JJ, Steele M, Makanjuola AD.

Nephrol Dial Transplant. 2012 Sep;27(9):3575-81. doi: 10.1093/ndt/gfs081. Epub 2012 Apr 18.

7.

A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.

Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B.

Am J Kidney Dis. 2012 Jan;59(1):102-7. doi: 10.1053/j.ajkd.2011.08.031. Epub 2011 Nov 14.

PMID:
22088576
8.

Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.

Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B.

J Am Soc Nephrol. 2005 Feb;16(2):539-45. Epub 2004 Dec 29.

9.

The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.

Thodis E, Passadakis P, Panagoutsos S, Bacharaki D, Euthimiadou A, Vargemezis V.

Adv Perit Dial. 2000;16:257-61.

PMID:
11045306
10.

Central venous catheter-associated bloodstream infections.

Newman N, Issa A, Greenberg D, Kapelushnik J, Cohen Z, Leibovitz E.

Pediatr Blood Cancer. 2012 Aug;59(2):410-4. doi: 10.1002/pbc.24135. Epub 2012 Apr 25.

PMID:
22535579
11.

Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis.

Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ.

Clin J Am Soc Nephrol. 2010 Oct;5(10):1799-804. doi: 10.2215/CJN.01270210. Epub 2010 Jul 1.

12.

Locking of tunneled hemodialysis catheters with gentamicin and heparin.

McIntyre CW, Hulme LJ, Taal M, Fluck RJ.

Kidney Int. 2004 Aug;66(2):801-5.

PMID:
15253736
13.
14.

The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.

Schmitz FJ, Fluit AC, Gondolf M, Beyrau R, Lindenlauf E, Verhoef J, Heinz HP, Jones ME.

J Antimicrob Chemother. 1999 Feb;43(2):253-9.

15.

Staphylococcus aureus infections in dialysis patients: focus on prevention.

Piraino B.

ASAIO J. 2000 Nov-Dec;46(6):S13-7. Review.

PMID:
11110288
16.

Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.

Cavdar C, Saglam F, Sifil A, Celik A, Atay T, Gungor O, Ozder A, Gulay Z, Camsari T.

Ren Fail. 2008;30(4):417-22. doi: 10.1080/08860220801964228.

PMID:
18569916
19.

Effect of antimicrobial locks for tunneled hemodialysis catheters on bloodstream infection and bacterial resistance: a quality improvement report.

Abbas SA, Haloob IA, Taylor SL, Curry EM, King BB, Van der Merwe WM, Marshall MR.

Am J Kidney Dis. 2009 Mar;53(3):492-502. doi: 10.1053/j.ajkd.2008.09.019. Epub 2009 Jan 15.

PMID:
19150156
20.

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.

Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR.

N Engl J Med. 1999 Feb 18;340(7):493-501.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk